Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library (Q36816741)

16 August 2017

title

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library (English)

1 reference

16 August 2017

1 reference

Begent RH

1

1 reference

16 August 2017

Verhaar MJ

2

1 reference

16 August 2017

Chester KA

3

1 reference

16 August 2017

Casey JL

4

1 reference

16 August 2017

Green AJ

5

1 reference

16 August 2017

Napier MP

6

1 reference

16 August 2017

Hope-Stone LD

7

1 reference

16 August 2017

Cushen N

8

1 reference

16 August 2017

Keep PA

9

1 reference

16 August 2017

Johnson CJ

10

1 reference

16 August 2017

Hawkins RE

11

1 reference

16 August 2017

Hilson AJ

12

1 reference

16 August 2017

Robson L

13

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

16 August 2017

1 reference

16 August 2017

volume

2

1 reference

16 August 2017

issue

9

1 reference

16 August 2017

page(s)

979-984

1 reference

Clinical issues in antibody design.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Phage antibodies: filamentous phage displaying antibody variable domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Making antibody fragments using phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Phage libraries for generation of clinically useful antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Disposition characteristics of macromolecules in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Synthetic human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Selection of phage antibodies by binding affinity

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates. Prepared by a Joint Committee of the: Cancer Research Campaign National Institute for Biological Standards

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Accurate quantification of 131I distribution by gamma camera imaging

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response

1 reference

https://api.crossref.org/works/10.1038%2FNM0996-979

7 January 2021

Identifiers

DOI

10.1038/NM0996-979

1 reference

16 August 2017

1 reference